Clinical trial
Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous…
NCT00411619 · Children's Hospital Medical Center, Cincinnati, Other · Completed
Key facts
| NCT number | NCT00411619 |
|---|---|
| Title | Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex |
| Official title | Everolimus (RAD001)Therapy of Giant Cell Astrocytomas in Patients With Tuberous Sclerosis Complex |
| Lead sponsor | Children's Hospital Medical Center, Cincinnati, Other |
| Collaborators | Novartis Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Tuberous Sclerosis, Subependymal Giant Cell Astrocytoma |
| Intervention type | Drug |
| Interventions | Everolimus |
| Enrollment | 28 |
| Start date | Jan 1, 2007 |
| Primary completion | Jan 1, 2014 |
| Completion | Jan 1, 2014 |
| First posted | Dec 14, 2006 |
| Last update posted | Oct 20, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: